Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
World Journal of Urology|February 4, 2025
Clinical effectiveness and safety of tislelizumab plus TKI as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): a single-center retrospective studyXi Zhong, Tingxuan Huang, Yulu Peng, et al.
Frontiers in Oncology|May 24, 2023
Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissectionZhen Li, Yixin Huang, Diwei Zhao, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
First-line PD-1 blockades combined with TKIs for metastatic non-clear cell renal cell carcinoma: a real-world multicenter retrospective studyXi Zhong, Tingxuan Huang, Yulu Peng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 12, 2023
G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC-I via PI3K/Akt Activation in Bladder CancerXianchong Zheng, Jiawei Chen, Minhua Deng, et al.
BMC Medicine|April 23, 2026
Camrelizumab plus apatinib for immune checkpoint inhibitor-naive patients with metastatic clear cell renal cell carcinoma after first-line tyrosine kinase inhibitor treatment failure: a single-arm phase 2 trialXiuyu Cai, Xia Zheng, Deling Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2022
Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell CarcinomaPei Dong, Xinyue Zhang, Yulu Peng, et al.
Cell Death & Disease|February 23, 2022
FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNAMinhua Deng, Ning Wang, Zhiyong Li, et al.
Scientific Reports|September 2, 2025
Perirenal fat thickness may be a significant predictor of prognosis and postoperative renal function in renal cancer surgery patientsHuancheng Tang, Ye Xie, Ling Yang, et al.
Cancer Medicine|April 27, 2022
Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosisZeshen Wu, Yulu Peng, Longbin Xiong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 10, 2024
Enhanced Oxidative Phosphorylation Driven by TACO1 Mitochondrial Translocation Promotes Stemness and Cisplatin Resistance in Bladder CancerMinhua Deng, Zhaohui Zhou, Jiawei Chen, et al.
Pageof 3